Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-018970
Filing Date
2024-04-29
Accepted
2024-04-29 16:01:42
Documents
26
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A dna-20240429.htm   iXBRL DEF 14A 652658
3 dna-20240429_g1.jpg GRAPHIC 985755
4 dna-20240429_g10.jpg GRAPHIC 232939
5 dna-20240429_g11.jpg GRAPHIC 900667
6 dna-20240429_g12.jpg GRAPHIC 462302
7 dna-20240429_g13.jpg GRAPHIC 250837
8 dna-20240429_g14.jpg GRAPHIC 468053
9 dna-20240429_g15.jpg GRAPHIC 227528
10 dna-20240429_g2.jpg GRAPHIC 156934
11 dna-20240429_g3.jpg GRAPHIC 31997
12 dna-20240429_g4.jpg GRAPHIC 49185
13 dna-20240429_g5.jpg GRAPHIC 14017
14 dna-20240429_g6.jpg GRAPHIC 212840
15 dna-20240429_g7.jpg GRAPHIC 14382
16 dna-20240429_g8.jpg GRAPHIC 171498
17 dna-20240429_g9.jpg GRAPHIC 302710
  Complete submission text file 0001628280-24-018970.txt   12207672

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20240429.xsd EX-101.SCH 935
29 EXTRACTED XBRL INSTANCE DOCUMENT dna-20240429_htm.xml XML 62417
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40097 | Film No.: 24890475
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)